Heart valve replacement study completes in china
NCT ID NCT05330468
Summary
This study followed 200 Chinese adults who received Abbott's Regent mechanical heart valve to replace a damaged aortic valve. Researchers monitored patients to confirm the valve's safety and performance over time. The study was required by Chinese regulators after the valve was already approved for use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VALVULAR HEART DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Hospital of Zunyi Medical University
Zunyi, China
-
Ningbo Medical Center Lihuili Hospital
Ningbo, China
-
The People's Hospital of Gaozhou
Gaozhou, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, China
-
Wuhan Union Hospital of China
Wuhan, China
Conditions
Explore the condition pages connected to this study.